Entyvio is a brand-name biologic drug administered through intravenous (IV) infusion or subcutaneous injection to treat moderate to severe ulcerative colitis and Crohn’s disease, with the goal of ...

Entyvio (vedolizumab) is a prescription drug used to treat Crohn’s disease and ulcerative colitis. Its mechanism of action (how it works) is to block specific inflammatory cells from entering the gut.

Humira (adalimumab) and Entyvio (vedolizumab) are brand-name drugs. They’re both prescribed for Crohn’s disease and ulcerative colitis in certain people. This article explains the main similarities ...

− ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy “With the FDA approval of subcutaneous ENTYVIO, patients and ...